✦ LIBER ✦

Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma

✍ Scribed by Kien T. Mai; Ghazi Elmontaser; D. Garth Perkins; Hossein M. Yazdi; William A. Stinson; Anthony Thijssen

Book ID: 109050707
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 304 KB
Volume: 94
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-4096.2004.04923.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytologic diagnosis of low-grade papilla

Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification

✍ Richard E. Whisnant; Sheldon I. Bastacky; N. Paul Ohori 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

## Abstract The 1998 World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification of urothelial neoplasms introduced a category called papillary neoplasm of low malignant potential (LMP) and separated it from low‐grade papillary urothelial carcinoma (LGPUC), whi

Proliferative activity is the most signi

Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder

✍ Achille Pich; Luigi Chiusa; Andrea Formiconi; Diego Galliano; Paola Bortolin; Al 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Background: Recurrence of transitional cell carcinoma of the bladder cannot be predicted accurately by traditional criteria alone. this study examined the value of cell proliferative activity, morphometry, and expression of p53, c-erbb-2, and bcl-2 oncogenes in predicting recurrence of superfici

Strong immunohistochemical expression of

Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur

✍ Francesca Barbisan; Alfredo Santinelli; Roberta Mazzucchelli; Antonio Lopez-Belt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

## Abstract ## BACKGROUND. Papillary urothelial neoplasm of low malignant potential (PUNLMP) is a clinically significant lesion because recurrence occurs in approximately 35% of patients. To date, it is not possible to identify those cases that will recur based on conventional histopathologic asse

Tubular carcinoma of the breast and asso

Tubular carcinoma of the breast and associated intra-epithelial lesions: a comparative study with invasive low-grade ductal carcinomas

✍ Sergio Fernández-Aguilar; Philippe Simon; Frédéric Buxant; Thierry Simonart; Jea 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 226 KB

Ovarian papillary serous tumors of low m

Ovarian papillary serous tumors of low malignant potential (Serous borderline tumors): A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma

✍ Alexander W. Kennedy; William R. Hart 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 900 KB

## Background: The clinical outcome of patients with ovarian serous tumors of low malignant potential (lmp) remains controversial, especially for those with extraovarian disease. we retrospectively reviewed our experience to study this question further, to assess the safety of conservative manageme